ES2321036T3 - Ratones artriticos transgenicos. - Google Patents

Ratones artriticos transgenicos. Download PDF

Info

Publication number
ES2321036T3
ES2321036T3 ES95920423T ES95920423T ES2321036T3 ES 2321036 T3 ES2321036 T3 ES 2321036T3 ES 95920423 T ES95920423 T ES 95920423T ES 95920423 T ES95920423 T ES 95920423T ES 2321036 T3 ES2321036 T3 ES 2321036T3
Authority
ES
Spain
Prior art keywords
artritical
transgenic
repertory
mouses
tcr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95920423T
Other languages
English (en)
Inventor
Christophe O Benoist
Diane J Mathis
V Kouskoff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Institut National de la Sante et de la Recherche Medicale INSERM
Universite de Strasbourg
ER Squibb and Sons LLC
Original Assignee
Centre National de la Recherche Scientifique CNRS
Institut National de la Sante et de la Recherche Medicale INSERM
Universite de Strasbourg
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Institut National de la Sante et de la Recherche Medicale INSERM, Universite de Strasbourg, ER Squibb and Sons LLC filed Critical Centre National de la Recherche Scientifique CNRS
Application granted granted Critical
Publication of ES2321036T3 publication Critical patent/ES2321036T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0306—Animal model for genetic diseases
    • A01K2267/0325—Animal model for autoimmune diseases
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/035—Animal model for multifactorial diseases
    • A01K2267/0368—Animal model for inflammation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Animal Husbandry (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

SE DESCRIBE UN MODELO ANIMAL TRANSGENICO. LA CONDICION ARTRITICA RESULTA DE MANIPULACIONES GENETICAS (O INMUNOLOGICAS) QUE RESULTAN EN LA LIMITACION SUSTANTIVA DEL REPERTORIO DE RECEPTORES DE LINFOCITOS T DEL ANIMAL EN RELACION AL REPERTORIO DE LINFOCITOS T DE UN ANIMAL DE CONTROL DE TIPO SALVAJE. EL REPERTORIO TCR DEL ANIMAL ARTRITICO, AUNQUE LIMITADO, ES FUNCIONALMENTE VIABLE. EN UN ASPECTO PREFERIDO, LA INVENCION SE REFIERE A RATONES ARTRITICOS TRANSGENICOS CUYA ARTRITIS RESULTA PROVOCADA POR (1) UN ALELO TRANSGENICO QUE CODIFICA Y EXPRESA LAS SUBUNIDADES {AL} Y {BE} DE TCR QUE SE COMBINAN EN LOS LINFOCITOS T DEL ANIMAL TRANSGENICO PARA FORMAR UN TCR QUE RECONOCE UN ANTIGENO QUE COMPRENDE UNO O MAS EPITOPOS DE UN OLIGOPEPTIDO DERIVADO DE AMINOACIDOS 41-61 DE LA RIBONUCLEASA PANCREATICA BOVINA Y/O (2) POR AUTOANTIGENOS ARTRITOGENICOS DE POLIPEPTIDOS DERIVADOS DE PROTEINAS ENDOGENOS. LOS RATONES ARTRITICOS TRANSGENICOS DE LA INVENCION PROPORCIONAN UN MODELO ANIMAL QUE IMITA FIELMENTE LA ARTRITIS REUMATOIDE Y GRACIAS A LA CUAL SE EVALUAN LAS COMPOSICIONES TERAPEUTICAS ANTIARTRITICAS Y ARTRITOGENICAS.
ES95920423T 1994-05-19 1995-05-18 Ratones artriticos transgenicos. Expired - Lifetime ES2321036T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/246,242 US5675060A (en) 1994-05-19 1994-05-19 Transgenic arthritic mice expressing a T-cell receptor transgene

Publications (1)

Publication Number Publication Date
ES2321036T3 true ES2321036T3 (es) 2009-06-01

Family

ID=22929875

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95920423T Expired - Lifetime ES2321036T3 (es) 1994-05-19 1995-05-18 Ratones artriticos transgenicos.

Country Status (10)

Country Link
US (1) US5675060A (es)
EP (1) EP0759985B1 (es)
JP (2) JP4304312B2 (es)
AT (1) ATE420174T1 (es)
CA (1) CA2189740C (es)
DE (1) DE69535902D1 (es)
DK (1) DK0759985T3 (es)
ES (1) ES2321036T3 (es)
PT (1) PT759985E (es)
WO (1) WO1995032285A2 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996039811A1 (en) * 1995-06-07 1996-12-19 Novartis Ag Immunocompromised animals comprising human synovial tissue
WO1997008303A1 (en) * 1995-08-30 1997-03-06 University Technologies International Inc. Transgenic animals expressing diabetogenic t-cell receptor transgenes
GB9720888D0 (en) * 1997-10-01 1997-12-03 Isis Innovation Tolerance
US6613958B1 (en) 1997-12-19 2003-09-02 Wyeth Transgenic mouse model for degeneration of type II collagen in joints
ES2269127T3 (es) * 1999-04-22 2007-04-01 Institut National De La Sante Et De La Recherche Medicale (Inserm) Utilizacion de la glucosa-6-fosfato isomerasa y de sus anticuerpos para el diagnostico y la terapia de la artritis, y el ensayo de compuestos antiartriticos.
AU5495600A (en) * 1999-06-17 2001-01-09 Fred Hutchinson Cancer Research Center Oligonucleotide arrays for high resolution hla typing
AU3086801A (en) * 2000-01-05 2001-07-16 Board Of Trustees Of The Leland Stanford Junior University Gene involved in mineral deposition and uses thereof
US6414218B1 (en) * 2000-01-18 2002-07-02 The General Hospital Corporation Mouse model for rheumatoid arthritis
AU2002220591A1 (en) * 2000-09-20 2002-04-02 Institut National De La Sante Et De La Recherche Medicale (I.N.S.E.R.M) Means for the identification of compounds capable of inhibiting karap-transduced signals
US20040197329A1 (en) * 2000-10-13 2004-10-07 Yasunori Nakayama Remedies or preventives for rheumatoid arthritis
US7973016B2 (en) * 2004-01-23 2011-07-05 Joslin Diebetes Center Methods of treating, reducing, or preventing autoimmune conditions
EA020950B1 (ru) 2007-09-17 2015-03-31 Баррик Гольд Корпорейшн Способ усовершенствования восстановления золота из двойных тугоплавких золотосодержащих руд
US7922788B2 (en) * 2007-09-18 2011-04-12 Barrick Gold Corporation Process for recovering gold and silver from refractory ores
US8262770B2 (en) 2007-09-18 2012-09-11 Barrick Gold Corporation Process for controlling acid in sulfide pressure oxidation processes
MX2023007788A (es) 2021-01-24 2023-11-17 Michael David Forrest Inhibidores de la atp sintasa, usos cosmeticos y terapeuticos.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2623509B1 (fr) * 1987-11-19 1990-04-20 Centre Nat Rech Scient Proteine de 17 kd a action angiogenique, son procede d'isolement a partir de lait de mammiferes, compositions therapeutiques la contenant, procede de detection et/ou de dosage et reactifs immunologiques de detection et de dosage des angiogenines de mammiferes, de leurs homologues et de leurs fragments
US5183949A (en) 1988-09-22 1993-02-02 The United States Of America As Represented By The Department Of Health And Human Services Rabbit model for diagnosing and testing vaccines or therapeutic agents against aids
US5175384A (en) * 1988-12-05 1992-12-29 Genpharm International Transgenic mice depleted in mature t-cells and methods for making transgenic mice
US5175383A (en) * 1989-02-17 1992-12-29 President And Fellows Of Harvard College Animal model for benign prostatic disease
US5174986A (en) * 1989-07-05 1992-12-29 Genpharm International, Inc. Method for determining oncogenic potential of a chemical compound
US5489742A (en) * 1990-10-23 1996-02-06 Board Of Regents, The University Of Texas System Transgenic rats and animal models of inflammatory disease
US5395753A (en) * 1993-02-19 1995-03-07 Theratech, Inc. Method for diagnosing rheumatoid arthritis

Also Published As

Publication number Publication date
CA2189740A1 (en) 1995-11-30
PT759985E (pt) 2009-04-15
JP4308217B2 (ja) 2009-08-05
WO1995032285A3 (en) 1996-02-15
JP4304312B2 (ja) 2009-07-29
EP0759985B1 (en) 2009-01-07
DE69535902D1 (de) 2009-02-26
ATE420174T1 (de) 2009-01-15
EP0759985A1 (en) 1997-03-05
WO1995032285A2 (en) 1995-11-30
DK0759985T3 (da) 2009-04-20
JPH10504701A (ja) 1998-05-12
US5675060A (en) 1997-10-07
CA2189740C (en) 2010-11-30
JP2006217918A (ja) 2006-08-24

Similar Documents

Publication Publication Date Title
ES2321036T3 (es) Ratones artriticos transgenicos.
ES2127831T3 (es) Unidades de expresion multicistronicas y su aplicacion.
EA200600525A1 (ru) Еро-имитирующие миметичекие антитела человека с центральной шарнирной областью, композиции, способы и применения
DK0555435T3 (da) DNA-sekvens, der koder bovint alfa-lactalbumin, og fremgangsmåder til anvendelse
ATE207532T1 (de) Synthetische stoffe und zusammensetzungen mit erhöhten zellbindungsvermögen
ATE232213T1 (de) Rekombinanter abkömmling des menschlichen faktors viii
MEP44408A (en) Anti-il-12 antibodies, compositions, methods and uses
MC2211A1 (fr) Production de polypeptides recombinants par une espece bovine et procedes transgeniques
DK0643767T3 (da) Osteogene peptider
ATE270337T1 (de) Materialen und methoden im zusammenhang mit bindung und präsentation von substanzen auf zelloberflächen
SE9100799L (sv) Rekombinant derivat av human faktor viii
DK0656945T3 (da) Stressproteinepitoper
ES2072918T3 (es) Mejoras en la produccion de polipeptidos.
ATE364703T1 (de) Herstellung von proteinen aus pro-proteinen durch fusionsproteine abgeleitet von furin oder furinanalogen
DE69431748D1 (de) Erhöhung des methionin-gehaltes in pflanzensamen durch expression von 10kd zein aus mais
DK191D0 (da) Ledersekvens, der frembringer en post-translational modifikation af polypeptider i bakterier, samt gen derfor
ES2138973T3 (es) Muteinas de il-6 exentas de cisteina.
YU199691A (sh) Receptor za humani interleukin-5
ES2052720T3 (es) Nuevos compuestos heterociclicos con propiedades plaguicidas.
PT728208E (pt) Endo-transglicosilase para o xiloglucano do tomate
ATE161543T1 (de) Aminoterminale prokollagen 1(i) peptide
ES2055066T3 (es) Anticuerpos monoclonales que reconocen el extremo n del gamma polipeptido natriuretico atrial, hibridomas que los producen y su preparacion y aplicacion.
NO974713L (no) Gener som koder for lymfocyttinterferon-regulatorisk faktor (LSIRF) polypeptider
DE69842239D1 (de) Zusammenfuegung von prokollagen
ES2076238T3 (es) Adnc que codifica la proteina 9 de placenta (pp9), su aislamiento y utilizacion.